FDA approves Eylea for BRVO
[ad_1]
Another treatment is available for macular edema related to branch retinal vein occlusion…
Regeneron Pharmaceuticals, Inc., announced that the FDA has approved Eylea (aflibercept) for macular edema following branch retinal vein occlusion.
[ad_2]
Return to main website.